Historical record - last NADAC publication: 3/20/2024
Product Information
CEFDINIR 300 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.5003 per EA under NDC 00781217660. Its NADAC has been published 540 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Sandoz Inc.NDC
00781217660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
3/20/2024
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA065330On Market Since
4/6/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 300 MG CAPSULE has been published 540 times since Nov 28, 2013, and over the history we have for it it has declined 62.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5003 per EA |
|---|---|
| All-time high | $1.3888 (Feb 12, 2014) |
| All-time low | $0.4325 (Jan 18, 2023) |
| Median price | $0.5346 |
| Average price | $0.6795 |
| Largest weekly change | +50.2% (Feb 22, 2017) |
| Weeks tracked | 540 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 300 MG CAPSULE, manufactured by Sandoz Inc., is $0.5003 per EA (NDC 00781217660), effective Mar 27, 2024.
How has the price of CEFDINIR 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFDINIR 300 MG CAPSULE has declined 62.8%. It has been tracked across 540 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFDINIR 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEFDINIR 300 MG CAPSULE has ranged from a low of $0.4325 (Jan 18, 2023) to a high of $1.3888 (Feb 12, 2014), with a median of $0.5346 per EA.
Are there cheaper alternatives to CEFDINIR 300 MG CAPSULE?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFDINIR 300 MG CAPSULE, is $0.4581 per EA — about 8% below CEFDINIR 300 MG CAPSULE.
Who manufactures CEFDINIR 300 MG CAPSULE?
CEFDINIR 300 MG CAPSULE (NDC 00781217660) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification